Business Description
BioVaxys Technology Corp
NAICS : 541714
SIC : 3741
ISIN : CA09076M1014
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | N/A | |||||
Equity-to-Asset | -0.44 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26 | |||||
3-Year EPS without NRI Growth Rate | -26 | |||||
3-Year FCF Growth Rate | 10.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.81 | |||||
9-Day RSI | 41.73 | |||||
14-Day RSI | 44.38 | |||||
6-1 Month Momentum % | 220 | |||||
12-1 Month Momentum % | 220 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -71.8 | |||||
Shareholder Yield % | -8.48 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1237.15 | |||||
ROA % | -446.37 | |||||
ROIC % | -161.2 | |||||
ROCE % | -313.39 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.4 | |||||
EV-to-EBITDA | -3.4 | |||||
EV-to-FCF | -8.57 | |||||
Earnings Yield (Greenblatt) % | -29.41 | |||||
FCF Yield % | -11.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioVaxys Technology Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.12 | ||
Beta | 1.25 | ||
Volatility % | 190.52 | ||
14-Day RSI | 44.38 | ||
14-Day ATR (C$) | 0.004445 | ||
20-Day SMA (C$) | 0.074 | ||
12-1 Month Momentum % | 220 | ||
52-Week Range (C$) | 0.01 - 0.1 | ||
Shares Outstanding (Mil) | 154.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioVaxys Technology Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioVaxys Technology Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
BioVaxys Technology Corp Frequently Asked Questions
What is BioVaxys Technology Corp(XCNQ:BIOV)'s stock price today?
When is next earnings date of BioVaxys Technology Corp(XCNQ:BIOV)?
Does BioVaxys Technology Corp(XCNQ:BIOV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |